Hybrid In Silico Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 Variants-Reference-Cited by-同舟云学术

Hybrid In Silico Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 Variants

Published:2021-09-17 Issue:5 Volume:4 Page:1675-1688
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Jain Sankalp¹,Talley Daniel C.¹,Baljinnyam Bolormaa¹,Choe Jun¹,Hanson Quinlin¹,Zhu Wei¹,Xu Miao¹,Chen Catherine Z.¹,Zheng Wei¹,Hu Xin¹,Shen Min¹,Rai Ganesha¹^ORCID,Hall Matthew D.¹^ORCID,Simeonov Anton¹,Zakharov Alexey V.¹^ORCID

Affiliation:

1. National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, United States

Funder

National Center for Advancing Translational Sciences

National Institutes of Health

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.1c00176

Reference55 articles.

1. A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin | Nature. https://www.nature.com/articles/s41586-020-2012-7 (accessed Aug 28, 2021).

2. COVID-19 Data in Motion. https://coronavirus.jhu.edu/ (accessed May 5, 2021).

3. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19

4. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

5. Anti-SARS and anti-HCV drugs repurposing against the Papain-like protease of the newly emerged coronavirus (2019-nCoV)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning and protein allostery;Trends in Biochemical Sciences;2023-04

2. Targeting Virus-Induced Reprogrammed Cell Metabolism via Glycolytic Inhibitors: An Effective Therapeutic Approach Against SARS-CoV-2;Mini-Reviews in Medicinal Chemistry;2023-02

3. Chronic Lung and Respiratory Conditions Affecting Lungs and Airways;ACS Pharmacology & Translational Science;2022-08-22

4. Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 Agents;ACS Pharmacology & Translational Science;2022-06-22

5. Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents;2022-03-16